期刊文献+

直肠类癌的诊断及治疗现状 被引量:14

The diagnosis and treatment of rectal carcinoid tumor
下载PDF
导出
摘要 本文结合近年研究报道,总结直肠类癌的内镜下表现,评价超声内镜检查对肿瘤术前分期的价值及对术后预后的判断,介绍在直肠类癌分子生物学水平上的诊断进展,浅析不同直径直肠类癌的治疗原则,并比较不同内镜治疗方法的特点,以及影响直肠类癌5年生存率预后的相关因素。 This article reviewed the endoscopic features of rectal carcinoid tumors, evaluated usefulness of endoscopic ultrasonography in the preoperative staging and prognosis of the tumors postoperatively, introduced the progresses of molecular dignosis, analyzed the therapeutic different sizes of tumors, compared the characteristic of ESD with EMR and the prognostic factors for 5-year survival rates of the tumors.
作者 李晓露 夏璐
出处 《胃肠病学和肝病学杂志》 CAS 2011年第6期495-497,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 直肠类癌 内镜 临床分析 治疗 Rectal carcinoid tumor Endoscopy Clinical analysis Treatment
  • 相关文献

参考文献1

二级参考文献16

  • 1Michael Hpfner,Andreas P Sutter,Alexander Huether,Viola Baradari,Hans Scherübl.Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer[J].World Journal of Gastroenterology,2006,12(35):5635-5643. 被引量:10
  • 2Neeltje Steeghs MD,Johan W. R. Nortier MD, PhD,Hans Gelderblom MD, PhD.Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments[J].Annals of Surgical Oncology.2007(2) 被引量:1
  • 3Elwyn Cabebe,Heather Wakelee.Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors[J].Current Treatment Options in Oncology.2007(1) 被引量:1
  • 4Masaubmi Shibuya.Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis[J].Angiogenesis.2006(4) 被引量:1
  • 5Thomas A. Abrams MD,Scott M. Schuetze MD, PhD.Targeted therapy for dermatofibrosarcoma protuberans[J].Current Oncology Reports.2006(4) 被引量:1
  • 6K. ?berg.Chemotherapy and biotherapy in the treatment of neuroendocrine tumours[J].Annals of Oncology.2001(2) 被引量:1
  • 7Kulke MH.Gastrointestinal neuroendocrine tumors: a role for targeted therapies?[].Endocrine Related Cancer.2007 被引量:1
  • 8Scherubl H,Faiss S,Zeitz M.[Neuroendocrine tumors of the gastrointestinal tract--diagnosis and therapy][].Deutsche Medizinische Wochenschrift.2003 被引量:1
  • 9Willett CG,Boucher Y,Duda DG,di Tomaso E,Munn LL,Tong RT,Kozin SV,Petit L,Jain RK,Chung DC,Sahani DV,Kalva SP,Cohen KS,Scadden DT,Fischman AJ,Clark JW,Ryan DP,Zhu AX,Blaszkowsky LS,Shellito PC,Mino-Kenudson M,Lauwers GY.Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients[].Journal of Clinical Oncology.2005 被引量:1
  • 10Cabebe E,Wakelee H.Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors[].Current Treatment Options in Oncology.2007 被引量:1

共引文献3

同被引文献96

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部